An expert discusses how payers and providers are embracing biosimilars and unbranded biologics as they enter the marketplace.
EP. 1: Overview of Originator Biologics, Biosimilars, and Unbranded Biologics
Definitions of originator biologics, biosimilars, and unbranded biologics, including their lifespan in the marketplace.
EP. 2: Evaluating Biosimilar Interchangeability
A glance at the process and regulations of switching, plus how an interchangeability study is conducted.
EP. 3: Evidence-Based Recommendations and Safety Considerations Surrounding Biosimilars
The role of evidence-based recommendations around biosimilars and unbranded biologics to increase patient care, plus how payers and providers evaluate biosimilars through clinical data across multiple indications.
EP. 4: Payer Perspective: Incentives For Biosimilars and Formulary Access
Savings and incentives associated with the utilization of biosimilars and unbranded biologics, including a look at how it impacts formulary access.
2 Clarke Drive Cranbury, NJ 08512